At MSK, we are leaders in the field of digital health. Our researchers, clinicians, and healthcare professionals are working on a wide range of cutting-edge AI and digital technologies to improve the lives of cancer patients here at MSK and worldwide.  

Our licensing portfolio spans applications from tech-enabled drug discovery; predictive AI for clinical decision support; dynamic AI radiology imaging and treatment planning; genomic testing for early detection and treatment response; computational pathology; and digital app solutions. 

MSK offers multiple pathways for strategic collaboration, including through the MSK iHub’s Accelerator and Collaboration opportunities—giving industry leaders in digital health access to innovators at MSK and other unique institutional assets. 

We are continuously advancing new digital health solutions, many of which may not yet be listed on our website. MSK’s Office of Entrepreneurship & Commercialization (OEC) oversees our digital innovation pipeline and serves as the primary contact for industry partnerships and licensing opportunities in the fields of surgery, radiology, pathology, drug discovery, and much more.